
ACT Brief: Community Research Financing Gaps, Neuroscience Endpoint Data, and Teva’s Biosimilar Deal
4.11.2026
0:00
1:57
In today’s ACT Brief, we examine why community research needs lasting financing and infrastructure, how electronic outcome tools can strengthen neuroscience endpoints, and how Teva is licensing two biosimilars from Samsung Bioepis.
Flere episoder fra "Applied Clinical Trials"



Gå ikke glip af nogen episoder af “Applied Clinical Trials” - abonnér på podcasten med gratisapp GetPodcast.








